The less invasive method could help men avoid some of the unpleasant side effects such as urinary incontinence and sexual dysfunction, which are known deterrents for patients facing potential prostatectomy.
Synthetic images are often of diagnostic quality and can be reliably used to assess clinically significant prostate cancer while also sparing patients from contrast exposure.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.